Nuveen Asset Management LLC Has $2.83 Million Position in TriMas Co. (NASDAQ:TRS)

Nuveen Asset Management LLC trimmed its holdings in TriMas Co. (NASDAQ:TRS - Free Report) by 24.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 114,974 shares of the industrial products company's stock after selling 37,681 shares during the period. Nuveen Asset Management LLC owned 0.28% of TriMas worth $2,827,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in TriMas by 3.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company's stock valued at $568,000 after buying an additional 834 shares during the last quarter. Deutsche Bank AG grew its position in shares of TriMas by 45.6% in the fourth quarter. Deutsche Bank AG now owns 36,305 shares of the industrial products company's stock valued at $893,000 after purchasing an additional 11,363 shares during the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of TriMas during the fourth quarter worth approximately $883,000. Bank of America Corp DE lifted its holdings in TriMas by 127.3% during the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock worth $86,400,000 after purchasing an additional 1,967,738 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in TriMas by 9.9% in the 4th quarter. Northern Trust Corp now owns 398,213 shares of the industrial products company's stock valued at $9,792,000 after purchasing an additional 35,798 shares during the period. 99.42% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have weighed in on TRS shares. BWS Financial reiterated a "buy" rating and set a $40.00 price objective on shares of TriMas in a research report on Wednesday, April 30th. Wall Street Zen raised shares of TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st.

Insider Activity at TriMas

In other TriMas news, Director Shawn Sedaghat bought 123,388 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were purchased at an average price of $23.83 per share, for a total transaction of $2,940,336.04. Following the completion of the transaction, the director now directly owns 1,024,362 shares in the company, valued at approximately $24,410,546.46. The trade was a 13.69% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Adrianne Shapira purchased 4,000 shares of TriMas stock in a transaction dated Thursday, June 5th. The stock was bought at an average price of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the purchase, the director now owns 8,476 shares in the company, valued at $218,850.32. This represents a 89.37% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 1,525,798 shares of company stock valued at $37,923,710 over the last three months. 14.20% of the stock is owned by insiders.

TriMas Price Performance

Shares of NASDAQ TRS traded up $0.27 during midday trading on Friday, reaching $25.94. The company's stock had a trading volume of 158,454 shares, compared to its average volume of 335,257. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The company has a market cap of $1.05 billion, a P/E ratio of 40.53 and a beta of 0.58. The business's 50 day moving average price is $23.40 and its two-hundred day moving average price is $24.03. TriMas Co. has a fifty-two week low of $19.33 and a fifty-two week high of $28.51.

TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. The firm had revenue of $241.67 million for the quarter, compared to analyst estimates of $235.41 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company's revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company earned $0.37 EPS. On average, analysts forecast that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were paid a $0.04 dividend. The ex-dividend date was Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.62%. TriMas's dividend payout ratio (DPR) is 20.78%.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.